-
1
-
-
33846457870
-
Cancer statistics 2007
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
-
(2007)
CA Cancer J Clin
, Issue.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
0026573360
-
The effect of surgical treatment on survival from early lung cancer
-
Implications for screening
-
Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992;101:1013-1018.
-
(1992)
Chest
, vol.101
, pp. 1013-1018
-
-
Flehinger, B.J.1
Kimmel, M.2
Melamed, M.R.3
-
3
-
-
0030912190
-
Revisions in the International System for Staging Lung Cancer
-
Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-11707
-
(1997)
Chest
, vol.111
, pp. 1710-11707
-
-
Mountain, C.F.1
-
4
-
-
18144364350
-
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
-
Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005;16:159-178.
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, pp. 159-178
-
-
Presta, M.1
Dell'Era, P.2
Mitola, S.3
Moroni, E.4
Ronca, R.5
Rusnati, M.6
-
5
-
-
0032858954
-
Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells
-
DOI 10.1002/(SICI)1097-0215(19991029)83:3<415::AID-IJC19>3.0.CO;2-Y
-
Berger W, Setinek U, Mohr T, et al. Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int J Cancer 1999;83:415-423. (Pubitemid 29455767)
-
(1999)
International Journal of Cancer
, vol.83
, Issue.3
, pp. 415-423
-
-
Berger, W.1
Setinek, U.2
Mohr, T.3
Kindas-Mugge, I.4
Vetterlein, M.5
Dekan, G.6
Eckersberger, F.7
Caldas, C.8
Micksche, M.9
-
6
-
-
9044228402
-
Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases
-
Gualandris A, Rusnati M, Belleri M, et al. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 1996;7:147-160. (Pubitemid 26049823)
-
(1996)
Cell Growth and Differentiation
, vol.7
, Issue.2
, pp. 147-160
-
-
Gualandris, A.1
Rusnati, M.2
Belleri, M.3
Nelli, E.E.4
Bastaki, M.5
Molinari-Tosatti, M.P.6
Bonardi, F.7
Parolini, S.8
Albini, A.9
Morbidelli, L.10
Ziche, M.11
Corallini, A.12
Possati, L.13
Vacca, A.14
Ribatti, D.15
Presta, M.16
-
7
-
-
31344474845
-
Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
-
DOI 10.1016/j.lungcan.2005.09.005, PII S0169500205004988
-
Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006;51:143-158. (Pubitemid 43144358)
-
(2006)
Lung Cancer
, vol.51
, Issue.2
, pp. 143-158
-
-
Bremnes, R.M.1
Camps, C.2
Sirera, R.3
-
8
-
-
1542719213
-
Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC
-
DOI 10.1016/j.ejcts.2003.11.031, PII S1010794003007553
-
Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 2004;25:443-448. (Pubitemid 38340585)
-
(2004)
European Journal of Cardio-thoracic Surgery
, vol.25
, Issue.3
, pp. 443-448
-
-
Iwasaki, A.1
Kuwahara, M.2
Yoshinaga, Y.3
Shirakusa, T.4
-
9
-
-
0037083515
-
Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma
-
DOI 10.1002/cncr.10352
-
Kojima H, Shijubo N, Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma. Cancer 2002;94:1083-1093. (Pubitemid 34150864)
-
(2002)
Cancer
, vol.94
, Issue.4
, pp. 1083-1093
-
-
Kojima, H.1
Shijubo, N.2
Abe, S.3
-
10
-
-
0035977176
-
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
-
DOI 10.1054/bjoc.2001.2137
-
Shou Y, Hirano T, Gong Y, et al. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Br J Cancer 2001;85:1706-1712. (Pubitemid 34081517)
-
(2001)
British Journal of Cancer
, vol.85
, Issue.11
, pp. 1706-1712
-
-
Shou, Y.1
Hirano, T.2
Gong, Y.3
Kato, Y.4
Yoshida, K.5
Ohira, T.6
Ikeda, N.7
Konaka, C.8
Ebihara, Y.9
Zhao, F.10
Kato, H.11
-
11
-
-
0030217819
-
The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers
-
DOI 10.1016/0959-8049(95)00620-6
-
Takanami I, Tanaka F, Hashizume T, et al. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 1996;32A: 1504-1509. (Pubitemid 26279115)
-
(1996)
European Journal of Cancer Part A
, vol.32
, Issue.9
, pp. 1504-1509
-
-
Takanami, I.1
Tanaka, F.2
Hashizume, T.3
Kikuchi, K.4
Yamamoto, Y.5
Yamamoto, T.6
Kodaira, S.7
-
12
-
-
0343471392
-
Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
-
DOI 10.1016/S0959-8049(96)00411-X, PII S095980499600411X
-
Volm M, Koomagi R, Mattern J, Stammler G. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer 1997;33:691-693. (Pubitemid 27223759)
-
(1997)
European Journal of Cancer Part A
, vol.33
, Issue.4
, pp. 691-693
-
-
Volm, M.1
Koomagi, R.2
Mattern, J.3
Stammler, G.4
-
13
-
-
0032769996
-
The expression of basic fibroblast growth factor (bFGF) in tumor- associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression
-
DOI 10.1016/S0046-8177(99)90139-9
-
Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G. The expression of basic fibroblast growth factor (bFGF) in tumorassociated stromal cells and vessels is inversely correlated with nonsmall cell lung cancer progression. Hum Pathol 1999;30:788-794. (Pubitemid 29325785)
-
(1999)
Human Pathology
, vol.30
, Issue.7
, pp. 788-794
-
-
Guddo, F.1
Fontanini, G.2
Reina, C.3
Vignola, A.M.4
Angeletti, A.5
Bonsignore, G.6
-
14
-
-
0031841108
-
Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients
-
Brattstrom D, Bergqvist M, Larsson A, et al. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res 1998;18:1123-1127. (Pubitemid 28239651)
-
(1998)
Anticancer Research
, vol.18
, Issue.2 A
, pp. 1123-1127
-
-
Brattstrom, D.1
Bergqvist, M.2
Larsson, A.3
Holmertz, J.4
Hesselius, P.5
Rosenberg, L.6
Brodin, O.7
Wagenius, G.8
-
15
-
-
0035985171
-
Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients
-
DOI 10.1016/S0169-5002(02)00027-2, PII S0169500202000272
-
Brattstrom D, Bergqvist M, Hesselius P, et al. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients. Lung Cancer 2002;37:57-63. (Pubitemid 34621459)
-
(2002)
Lung Cancer
, vol.37
, Issue.1
, pp. 57-63
-
-
Brattstrom, D.1
Bergqvist, M.2
Hesselius, P.3
Larsson, A.4
Lamberg, K.5
Wernlund, J.6
Brodin, O.7
Wagenius, G.8
-
16
-
-
0347931821
-
Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer
-
DOI 10.1016/j.lungcan.2003.07.007
-
Brattstrom D, Bergqvist M, Hesselius P, Larsson A, Wagenius G, Brodin O. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer 2004;43: 55-62. (Pubitemid 38096292)
-
(2004)
Lung Cancer
, vol.43
, Issue.1
, pp. 55-62
-
-
Brattstrom, D.1
Bergqvist, M.2
Hesselius, P.3
Larsson, A.4
Wagenius, G.5
Brodin, O.6
-
17
-
-
0037105784
-
Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer
-
Joensuu H, Anttonen A, Eriksson M, et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 2002;62:5210-5217. (Pubitemid 35024592)
-
(2002)
Cancer Research
, vol.62
, Issue.18
, pp. 5210-5217
-
-
Joensuu, H.1
Anttonen, A.2
Eriksson, M.3
Makitaro, R.4
Alfthan, H.5
Kinnula, V.6
Leppa, S.7
-
18
-
-
0035144946
-
Increased serum levels of basic fibroblast growth factor in lung cancer patients: Relevance to response of therapy and prognosis
-
DOI 10.1016/S0169-5002(00)00187-2, PII S0169500200001872
-
Ueno K, Inoue Y, Kawaguchi T, Hosoe S, Kawahara M. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer 2001;31: 213-219. (Pubitemid 32107018)
-
(2001)
Lung Cancer
, vol.31
, Issue.2-3
, pp. 213-219
-
-
Ueno, K.1
Inoue, Y.2
Kawaguchi, T.3
Hosoe, S.4
Kawahara, M.5
-
19
-
-
34948848203
-
Why targeted therapy hasn't worked in advanced cancer
-
Arbiser JL. Why targeted therapy hasn't worked in advanced cancer. J Clin Invest 2007;117:2762-2765.
-
(2007)
J Clin Invest
, vol.117
, pp. 2762-2765
-
-
Arbiser, J.L.1
-
20
-
-
34948905351
-
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis
-
DOI 10.1172/JCI32479
-
Nissen LJ, Cao R, Hedlund EM, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 2007;117:2766-2777. (Pubitemid 47529608)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.10
, pp. 2766-2777
-
-
Nissen, L.J.1
Cao, R.2
Hedlund, E.-M.3
Wang, Z.4
Zhao, X.5
Wetterskog, D.6
Funa, K.7
Brakenhielm, E.8
Cao, Y.9
-
21
-
-
0037172970
-
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea
-
DOI 10.1073/pnas.062040199
-
Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 2002;99:8868-8873. (Pubitemid 34693650)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.13
, pp. 8868-8873
-
-
Kubo, H.1
Cao, R.2
Brakenhielm, E.3
Makinen, T.4
Cao, Y.5
Alitalo, K.6
-
22
-
-
36749024002
-
Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non-small cell lung cancer
-
DOI 10.1158/1078-0432.CCR-07-0414
-
Donnem T, Al-Saad S, Al-Shibli K, et al. Inverse Prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007;13:6649-6657. (Pubitemid 350206800)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.22
, pp. 6649-6657
-
-
Donnem, T.1
Al-Saad, S.2
Al-Shibli, K.3
Delghandi, M.P.4
Persson, M.5
Nilsen, M.N.6
Busund, L.-T.7
Bremnes, R.M.8
-
23
-
-
58049193595
-
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells
-
Donnem T, Al-Shibli K, Al-Saad S, Delghandi MP, Busund LT, Bremnes RM. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells. Lung Cancer 2009;63:277-283.
-
(2009)
Lung Cancer
, vol.63
, pp. 277-283
-
-
Donnem, T.1
Al-Shibli, K.2
Al-Saad, S.3
Delghandi, M.P.4
Busund, L.T.5
Bremnes, R.M.6
-
24
-
-
58149106094
-
Prognostic impact of platelet-derived growth factors in NSCLC tumor and stromal cells
-
Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM. Prognostic impact of platelet-derived growth factors in NSCLC tumor and stromal cells. J Thorac Oncol 2008;3:963-970.
-
(2008)
J Thorac Oncol
, vol.3
, pp. 963-970
-
-
Donnem, T.1
Al-Saad, S.2
Al-Shibli, K.3
Andersen, S.4
Busund, L.T.5
Bremnes, R.M.6
-
26
-
-
30144443269
-
Paradoxical roles of the immune system during cancer development
-
DOI 10.1038/nrc1782
-
de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6: 24-37. (Pubitemid 43053650)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.1
, pp. 24-37
-
-
De Visser, K.E.1
Eichten, A.2
Coussens, L.M.3
-
27
-
-
52649163840
-
Prognostic impact of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
-
Al-Shibli K, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic impact of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008;15:5220-5227.
-
(2008)
Clin Cancer Res
, vol.15
, pp. 5220-5227
-
-
Al-Shibli, K.1
Donnem, T.2
Al-Saad, S.3
Persson, M.4
Bremnes, R.M.5
Busund, L.T.6
-
28
-
-
0034638923
-
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
-
DOI 10.1038/sj.onc.1203969
-
Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000;19:6122-6129. (Pubitemid 32059462)
-
(2000)
Oncogene
, vol.19
, Issue.53
, pp. 6122-6129
-
-
Saaristo, A.1
Karpanen, T.2
Alitalo, K.3
-
29
-
-
0032933883
-
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
-
Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999; 154:1381-1390. (Pubitemid 29226433)
-
(1999)
American Journal of Pathology
, vol.154
, Issue.5
, pp. 1381-1390
-
-
Valtola, R.1
Salven, P.2
Heikkila, P.3
Taipale, J.4
Joensuu, H.5
Rehn, M.6
Pihlajaniemi, T.7
Weich, H.8
DeWaal, R.9
Alitalo, K.10
-
31
-
-
4143121247
-
Dose-dependent response of FGF-2 for lymphangiogenesis
-
DOI 10.1073/pnas.0404272101
-
Chang LK, Garcia-Cardena G, Farnebo F, et al. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A 2004;101:11658-11663. (Pubitemid 39095352)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.32
, pp. 11658-11663
-
-
Chang, L.K.1
Garcia-Cardena, G.2
Farnebo, F.3
Fannon, M.4
Chen, E.J.5
Butterfield, C.6
Moses, M.A.7
Mulligan, R.C.8
Folkman, J.9
Kaipainen, A.10
-
32
-
-
30744477450
-
Lymphangiogenesis in development and human disease
-
DOI 10.1038/nature04480, PII NATURE04480
-
Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-953. (Pubitemid 43093960)
-
(2005)
Nature
, vol.438
, Issue.7070
, pp. 946-953
-
-
Alitalo, K.1
Tammela, T.2
Petrova, T.V.3
|